Navarro-Navajas, A.; Casallas, I.; Isaza, D.; Ortiz, P.; Baracaldo-SantamarÃa, D.; Calderon-Ospina, C.-A.
Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity. Medicina 2022, 58, 855.
https://doi.org/10.3390/medicina58070855
AMA Style
Navarro-Navajas A, Casallas I, Isaza D, Ortiz P, Baracaldo-SantamarÃa D, Calderon-Ospina C-A.
Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity. Medicina. 2022; 58(7):855.
https://doi.org/10.3390/medicina58070855
Chicago/Turabian Style
Navarro-Navajas, Alberto, Ingrid Casallas, Daniel Isaza, Paola Ortiz, Daniela Baracaldo-SantamarÃa, and Carlos-Alberto Calderon-Ospina.
2022. "Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity" Medicina 58, no. 7: 855.
https://doi.org/10.3390/medicina58070855
APA Style
Navarro-Navajas, A., Casallas, I., Isaza, D., Ortiz, P., Baracaldo-SantamarÃa, D., & Calderon-Ospina, C.-A.
(2022). Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity. Medicina, 58(7), 855.
https://doi.org/10.3390/medicina58070855